Patel Sanjiv

President and CEO, DirectorRelay Therapeutics, Inc. (RLAY) · full profile →Form 4 · filed Aug 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$980K
Net Open-Market Flow
-$980K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 17, 2026Sell(S)48K$20.33$980K568K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-355502) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.